Short answer
Quanterix Corp (QTRX) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CEO Everett Cunningham resigned November 18, 2026, leaving both the CEO role and Board seat.
Quanterix Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO Everett Cunningham resigned November 18, 2026, leaving both the CEO role and Board seat
- Departure attributed to another opportunity, with no reported disagreements over operations, disclosures, accounting, or legal matters
- Chief Commercial Officer James Gute appointed interim CEO pending a permanent search
- Gute joined Quanterix in August 2026, limiting his tenure and potentially increasing execution risk during transition
- Interim CEO compensation: $750,000 annualized salary through the assignment
Item 7.01 · Regulation FD Disclosure
- CEO Mr. Cunningham resigned, creating leadership-transition risk for Quanterix
- Mr. Gute appointed as successor, signaling immediate management continuity
- Exhibit 99.1 contains the company’s announcement and any transition details
Item EX-99.1 · Exhibit EX-99.1
- CEO Everett Cunningham departed immediately to pursue another healthcare opportunity, creating near-term leadership uncertainty
- Chief Commercial Officer Jim Gute appointed interim President and CEO, leveraging commercial and diagnostics experience
- Board launched an internal and external CEO search with a nationally recognized executive search firm
- Cunningham available through December 11, 2026 to support transition, limiting immediate handoff disruption
- Quanterix reaffirmed its 2026 financial outlook, preserving current expectations despite the leadership change
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quanterix Corp 8-K filings
Get the next QTRX 8-K as it lands
Follow QTRX for push alerts, or ask the research agent what this filing means.